iBio, Inc.
(NYSE Amex Equities : IBIO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
ARGXargenx SE 1.48%320.630.0%$122.71m
ICLRICON plc 3.86%226.042.8%$118.85m
VRXValeant Pharmaceuticals International, Inc. -0.46%9.8214.1%$57.78m
BGXXBright Green Corp. -16.98%6.550.0%$24.85m
RVMDRevolution Medicines, Inc. 5.41%16.750.0%$11.42m
EVOKEvoke Pharma, Inc. -6.23%2.8639.7%$10.26m
AMRNAmarin Corp. Plc -0.87%1.421.5%$9.59m
USNAUSANA Health Sciences, Inc. 1.47%71.614.2%$5.07m
ANIKAnika Therapeutics, Inc. 2.37%22.229.8%$2.33m
ATOSAtossa Therapeutics, Inc. 4.57%0.950.2%$1.43m
NATRNature's Sunshine Products, Inc. 2.03%12.540.4%$1.27m
CLVRClever Leaves Holdings, Inc. -0.90%1.110.0%$0.82m
CDXCChromadex Corp. -0.29%1.752.7%$0.76m
SMFLSmart for Life, Inc. 0.95%0.480.0%$0.66m
IBIOiBio, Inc. 3.74%0.250.2%$0.61m

Company Profile

iBio, Inc. is a biotechnology company, which engages in the development and manufacture of biotherapeutics using its FastPharming Manufacturing System. The firm operates through the Biopharmaceuticals and Bioprocessing segments. The Biopharmaceuticals segment includes the Therapeutics unit, which is focused on oncology as well as fibrotic and infectious diseases, and the Vaccines unit, which is focused on human and animal health vaccines. The Bioprocessing segment includes Services (FastPharming, Process Development, Manufacturing, as well as Bioanalytical and other services) and Products (growth factors, lectins, and monoclonal antibodies) for research and further manufacturing uses, collectively known as Research & Bioprocess products (RBP). The company was founded by Robert B. Kay on April 15, 1993 and is headquartered in New York, NY.